Sudden cardiac death - Preventable - Reversible

American Journal of Critical Care

Volumn 6, Issue 6, 1997, Pages 472-482

  Futterman, Laurie G ^a   Lemberg, Louis ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MALE; MIDDLE AGED; REVIEW; RISK FACTOR; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031279909     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc1997.6.6.472     Document Type: Article

References (43)

1. Kendall MJ, Lynch KP, Hjalmarson A. β-Blockers and sudden cardiac death. Ann Intern Med. 1995;123:358-367.
2. Rajman I, Kendall MJ. Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs. Postgrad Med. 1993;69:903-911.
3. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 1993;88:2953-2959.
4. Owens DK, Sanders GD, Harris RA, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1-12.
5. Demirovic J, Myerburg RJ. Epidemiology of sudden coronary death: an overview. Progr Cardiovasc Dis. 1994;37:39-48.
6. Valle GA, Valle BK, Lemberg L. Circadian influence on coronary events. Heart Lung. 1988;17:586-593.
7. Engel GL. Sudden and rapid death during psychological stress. Folklore or folk wisdom? Ann Intern Med. 1971;74:771-782.
8. Deedwania P, Carbajal E. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 1990;81:748-756.
9. Pasternak RC, Grundy SM, Levy D, and Thompson PD. Task Force 3: Spectrum of risk factors for coronary heart disease. J Am Coll Cardiol. 1996;27: 978-987.
10. Fuster V, Gotto AM, Libby P, et al. Task Force One: Pathogenesis of coronary disease: the biologic role of risk factors. J Am Coll Cardiol. 1996;27:964-1047.
11. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
12. Ravinikar VA. Hormone replacement therapy in the primary prevention of cardiovascular disease: benefits, risks and compliance issues. In: Wenger NK, Speroff P, et al, eds. Cardiovascular Health and Diseases in Women. Greenwich, Conn: LeJacq Communications Inc, 1993:181.
13. Scrutinio D, Lagioia R, Ricci A, Clemente M, Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. Eur Heart J. 1994;15:1089-1095.
14. Pearson TA, Fuster V. Executive summary. J Am Coll Cardiol. 1996;27(5):961-963.
15. Forrester JS, Merz NB, Bush TL, et al. Task force 4: Efficacy of risk factor management. J Am Coll Cardiol. 1996;27:991-1003.
16. Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med. 1983;309:396-403.
17. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med. 1985;313:1369-1370.
18. Theroux P, Ouiment H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
19. The RISC Group: risk of myocardial infarction and death during treatment with low-dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 1990;336:827-830.
20. Byington RP, Furberg CD, Crouse III JR, Espeland MA, Bond MG. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol. 1995;76:54c-59c.
21. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
22. National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1329-1445.
23. Stephens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary artery disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
24. Gross JN, Sackstein RD, Song SL, et al. The antitachycardiac implantable cardioverter defibrillator: impact on patient selection and outcome. Pacing Clin Electrophysiol. 1993;16:165-169.
25. Do TM, Rubal BJ, Bulgrin JR, Gilman JK. Time-frequency analysis of ECG for late potentials in sudden cardiac death survivors and post-myocardial infarction patients. Biomed Sci Instrum. 1995;31:109-114.
26. Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1996;27:690-695.
27. Trappe HJ, Wenzlaff P. Cardioverter defibrillator therapy as a bridge to heart transplant. Pacing Clin Electrophysiol. 1995;18:622-631.
28. Mechcatie E. New ECG measure may mark risk for sudden death. Intern Med News. 1997;30(13):1-2.
29. Hamalainen H, Lurila OJ, Kallio V, Knuts LR. Reduction in sudden deaths and coronary mortality in myocardial infarction patients after rehabilitation. Eur Heart J. 1995;16:1839-1844.
30. Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995;92:2-4.
31. Bigger JT. Epidemiology and causes of sudden death in the general population. American College of Cardiology Extended Learning, March 16-17, 1997.
32. Moss AJ, Hall WJ, Cannom DS, et al. Multicenter automatic defibrillator implantation trial (MADIT). Circulation. 1996;94(8):I-567. Abstract.
33. Dracup K, Moser DK, Guzy PM, Taylor SE, Marsden C. Is cardiopulmonary resuscitation training deleterious for family members of cardiac patients? Am J Public Health. 1994;84(1):116-118.
34. Mehra MR, Ventura HO, Stapleton DD, et al. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac vasculopathy. J Heart Lung Transpl. 1995;14:632-639.
35. Futterman L, Lemberg L. Sudden death in athletes. Am J Crit Care. 1995;4(3):239-243.
36. Marian AJ, Kelly D, Mares A, et al. A missense mutation in the B myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy. J Sports Med Phys Fitness. 1994;34:1-10.
37. Ambrose JA, Fuster V. Can we predict future acute coronary events in patients with stable coronary artery disease. JAMA. 1997;277:343-344.
38. Autschbach R, Falk V, Gonska BD, Dalichau H. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death. Pacing Clin Electrophysiol. 1994;17:552-557.
39. Kendall MJ. Prevention of sudden death with β-blockers. Adv Cardiovasc Med. 1996;3(6):1-8.
40. Miorelli M, Buja G, Melacini P, Nava A. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. Int J Cardiol. 1994;45:121-127.
41. Mulcahy D, Husain S, Zalos G, et al. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease. JAMA. 1997;277(4):318-324.
42. Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. MADIT Executive Committee. Pacing Clin Electrophysiol. 1991;14:920-927.
43. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995;61:1360s-1375s.